UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From gene panel testing to new molecularly targeted therapy

International cancer conference journal, 2024-04, Vol.13 (2), p.75-75

Matsumura, Noriomi

2024

Volltextzugriff (PDF)

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma

Scientific reports, 2020-02, Vol.10 (1), p.2757-2757, Article 2757

2020

Volltextzugriff (PDF)

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

Clinical cancer research, 2017-01, Vol.23 (2), p.587-599

2017

Volltextzugriff (PDF)

Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine‐induced disease

Cancer science, 2022-10, Vol.113 (10), p.3313-3320

2022

Volltextzugriff (PDF)

Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition

Clinical cancer research, 2021-09, Vol.27 (17), p.4669-4679

2021

Volltextzugriff (PDF)

Recent Concepts of Ovarian Carcinogenesis : Type I and Type II

BioMed research international, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine–induced adverse events

Cancer science, 2023-04, Vol.114 (4), p.1218-1228

2023

Volltextzugriff (PDF)

Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs

International journal of clinical oncology, 2022-06, Vol.27 (6), p.1001-1012

2022

Volltextzugriff (PDF)

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

British journal of cancer, 2020-03, Vol.122 (6), p.778-788

2020

Volltextzugriff (PDF)

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

International journal of clinical oncology, 2016-06, Vol.21 (3), p.462-473

2016

Volltextzugriff (PDF)

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

Nature communications, 2018-04, Vol.9 (1), p.1685-12, Article 1685

2018

Volltextzugriff (PDF)

The roles and limitations of bevacizumab in the treatment of ovarian cancer

International journal of clinical oncology, 2022-07, Vol.27 (7), p.1120-1126

2022

Volltextzugriff (PDF)

Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy

Cancers, 2020-06, Vol.12 (6), p.1676

2020

Volltextzugriff (PDF)

Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts

International journal of clinical oncology, 2020-01, Vol.25 (1), p.51-58

2020

Volltextzugriff (PDF)

HER2-amplified endometrial carcinoma and AFP-producing endometrial carcinoma

Modern pathology, 2022-12, Vol.35 (12), p.2027-2028

2022

Volltextzugriff (PDF)

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

Nature communications, 2019-10, Vol.10 (1), p.4965-14, Article 4965

2019

Volltextzugriff (PDF)

Comment on ‘Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer’. (Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639)

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231168509-17588359231168509

2023

Volltextzugriff (PDF)

Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy

The journal of obstetrics and gynaecology research, 2018-02, Vol.44 (2), p.298-302

2018

Volltextzugriff (PDF)

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction

Clinical cancer research, 2013-03, Vol.19 (6), p.1363-1374

2013

Volltextzugriff (PDF)

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

International journal of clinical oncology, 2009-10, Vol.14 (5), p.383-391

2009

Volltextzugriff (PDF)

Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer

Annals of translational medicine, 2023-03, Vol.11 (5), p.229-229

2023

Volltextzugriff (PDF)

Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries

Scientific data, 2024-02, Vol.11 (1), p.171-171, Article 171

2024

Volltextzugriff (PDF)

Superparamagnetic iron oxide as a tracer for sentinel lymph node detection in uterine cancer: a pilot study

Scientific reports, 2020-05, Vol.10 (1), p.7945-7945, Article 7945

2020

Volltextzugriff (PDF)

Association between preterm delivery and bacterial vaginosis with or without treatment

Scientific reports, 2019-01, Vol.9 (1), p.509, Article 509

2019

Volltextzugriff (PDF)

Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study

Cancer science, 2023-06, Vol.114 (6), p.2515-2523

2023

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

From gene panel testing to new molecularly targeted therapy

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine‐induced disease

Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition

Recent Concepts of Ovarian Carcinogenesis : Type I and Type II

Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine–induced adverse events

Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

The roles and limitations of bevacizumab in the treatment of ovarian cancer

Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy

Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts

HER2-amplified endometrial carcinoma and AFP-producing endometrial carcinoma

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

Comment on ‘Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer’. (Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639)

Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer

Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries

Superparamagnetic iron oxide as a tracer for sentinel lymph node detection in uterine cancer: a pilot study

Association between preterm delivery and bacterial vaginosis with or without treatment

Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study

Suchergebnisse filtern